Common Contracts

COMMON STOCK PURCHASE WARRANT VACCINEX, INC.

Common Stock Purchase Warrant • April 1st, 2024 • Vaccinex, Inc. • Pharmaceutical preparations

• Contract Type
  Common Stock Purchase Warrant
• Filed
  April 1st, 2024
• Company
  Vaccinex, Inc.
• Industry
  Pharmaceutical preparations

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Alzheimer’s Drug Discovery Foundation or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after March 29, 2024 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on March 29, 2029 (the “Termination Date”), but not thereafter, to subscribe for and purchase from Vaccinex, Inc., a Delaware corporation (the “Company”), up to 229,057 shares of common stock, par value $0.0001 per share (the “Common Stock”) (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

SERIES A COMMON STOCK PURCHASE WARRANT INTUITIVE MACHINES, INC.

Common Stock Purchase Warrant • January 30th, 2024 • Intuitive Machines, Inc. • Search, detection, navagation, guidance, aeronautical sys • New York

• Contract Type
  Common Stock Purchase Warrant
• Filed
  January 30th, 2024
• Company
  Intuitive Machines, Inc.
• Industry
  Search, detection, navagation, guidance, aeronautical sys
• Jurisdiction
  New York

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Ghaffarian Enterprises, LLC, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on January 29, 2029 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Intuitive Machines, Inc., a Delaware corporation (the “Company”), up to an aggregate of 4,150,780 shares (as subject to adjustment hereunder, the “Warrant Shares”) of, at the election of the Holder, the Company’s Class A common stock, par value $0.0001 per share (“Class A Common Stock”), the Company’s Class C common stock, par value $0.0001 per share (“Class C Common Stock” and, together with Class A Common Stock, “Common Stock”) or a combination thereof. The purchase price of one share of Common Stock under this Wa